Observational Study of the Quality of Life of New Ostomates Using SenSura Mio Appliances With BodyFit Technology

NCT ID: NCT04635215

Last Updated: 2021-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

195 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-27

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An ostomy is defined by the connection of a viscera to the skin, outside its natural location, by diversion from the digestive or urinary tract. The bodily injury, i.e. the creation of a stoma, has familiar, social and professional consequences. Personalized care, with the help of an ostomy nurse, is essential to accompany the ostomy patient in the changes of his or her life habits. In addition, the progress made in the various appliances, pouching and irrigation systems, contribute to improving the quality of life of these people.

In this context of adapted support, COLOPLAST has developed a range of ostomy pouches, the SenSura Mio BodyFit® technology range, for digestive or urinary stomas. The diversity of the devices makes it possible to find the most suitable combination to adapt to the morphology thanks to an elastic adhesive for a secure fit to individual body shape, and the textile materials used make it possible to optimize wearing comfort.

The aim of this study is to evaluate the quality of life of patients with recent ostomies with one of COLOPLAST's SenSura Mio devices at three months after discharge from the hospital. The condition of the skin around the stoma and the level of satisfaction of the patients will also be evaluated. Finally, the results obtained aim to identify factors predictive of a better quality of life in order to improve management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Today, there are about 80,000 people with ostomies in France and 19,000 ostomies are created each year.

An ostomy is defined by a viscera reaching the skin, outside its natural location, by diversion of the digestive (enterostomy) or urinary (ureterostomy) tract. Digestive ostomies are temporary or permanent palliative surgeries that consist of connecting a segment of the healthy digestive tract to the surface of the skin, either downstream or upstream of a lesion. There are several reasons for this type of stoma: following colorectal cancer or IBD (chronic inflammatory bowel disease), or to decompress and drain the digestive tract in occlusion, or to protect a digestive anastomosis by temporarily diverting the intestinal flow. Urinary ostomies are usually performed following bladder cancer or neurogenic bladder that has resulted in the removal of the bladderr. The urinary tract is then diverted to allow the evacuation of urine into an artificial pouch.

The bodily injury, the creation of a stoma, can have serious familiar, social and professional repercussions. An early follow-up from the preoperative phase and long-term technical and psychological support promote an adaptation of quality. Helping the patient to live well with his disability is a complex task that mobilizes the skills of a multidisciplinary team of caregivers. Mastery of surgical techniques for the creation of ostomies and close collaboration between the surgeon and the stoma therapist are essential for the personalized care of ostomy patients.

Advances in various devices, bag systems and irrigation systems are concrete means that contribute greatly to improving the patient's quality of life. In this context of technological advances, COLOPLAST has developed a range of devices for incontinent digestive and urinary stomas, SenSura Mio Technology BodyFit®. This range of pouches adapts to peristomal morphology and body movements due to an elastic adhesive for a secure fit to individual body shapes. In addition, the pouches are designed to remain discreet and maximize wearing comfort due to a neutral-grey color water-repellent textile material, invisible even under white clothing, and a full-circle prefilter to differ filter saturation for proven reduction of ballooning.

The objective of this study is to evaluate the use of SenSura Mio products in real-life conditions in patients with recent ostomies. For this purpose, we will use the Stoma-QoL specific quality of life scale, as well as the Peristomal Skin Condition Rating Scale (DET Score).

The Stoma-QoL tool was developed and validated specifically for ostomy patients in 2005 at the initiative of COLOPLAST and in close collaboration with international experts, with the aim of evaluating the impact of ostomy related concerns on the quality of life of ostomy patients on the one hand, and improving and facilitating their follow-up on the other hand. Potential items were formulated based on the results of a series of semi-structured interviews conducted with 169 adult subjects who had ostomies for a long time. The process resulted in a preliminary version of 37 items, administered repeatedly to 182 subjects with an ileostomy or colostomy. A psychometric selection of the items was performed using a Rasch model. The Stoma-QOL questionnaire has in its most refined version 20 questions covering 4 domains, not scored independently: sleep, intimate relationships, relationships with family and close friends, and social relationships with other people. This 20-item version has been validated internationally in ileo- or colostomized patients. On average, the value of the overall Stoma-QoL score was 58.5 with the lowest mean value (53.8) observed in France and the highest mean value (62.6) in Denmark. Stoma-QoL can be offered to ostomy patients who have already lived at least 1 month with their stoma and appliance.

The DET Score -also known as the Ostomy Skin Tool- is a measurement tool for assessing the extent and severity of peristomal skin problems. It was developed by Martins et al in 2008, at the initiative of COLOPLAST and in close collaboration with international experts, with the intention of improving the monitoring of peristomal skin conditions in ostomy patients and optimizing communication between healthcare professionals. The DET Score is divided into three areas: Discoloration (D), Erosion (E) and Tissue Proliferation (T). For each area, a maximum of 5 points can be awarded, 3 for the affected area and 2 for severity. The scores for each domain should be based solely on observations of each subject's skin, not on past experience. Photographs of problem skin are included in this rating scale and can be used as a guide for scoring severity. Once the score for each domain has been assessed, a total score is calculated by adding the numbers. A score of 0 represents normal skin while a score of 15 represents maximum skin severity around the stoma. The DET Score was validated in 2011 18: it is now widely used and has been translated into several languages. Skin problems are considered mild if DET Score ≤ 4; moderate if DET Score \< 7; severe if DET Score ≥ 7. The mean value observed in an international study of more than 3,000 ostomy patients was 2.5 (± 2.8).

The objectives of the present study are multiple: to evaluate the quality of life of patients with recent ostomies using SenSura Mio appliances during the first three months following hospital discharge, to evaluate the condition of the peristomal skin during this same period and to look for factors predictive of a better quality of life. The data collected in this study will help to better document the factors influencing the quality of life of French patients with recent ostomies and the value of using the new SenSura Mio appliances. This study will also provide a better understanding of the incidence of skin problems in the early follow-up phase (first three months) and the main corrective actions taken by the ostomy nurses.

The QoL Mio study population will be composed of adults with recent ostomies (stoma preparation \< 1 month), with liquid effluent (right colostomy, ileostomy, jejunostomy or urostomy), for whom healthcare professionals have recommended the use of SenSura Mio devices for ostomy care as part of the routine care. Because liquid effluents can seep under the adhesive on the skin, this population (ostomy with liquid effluents) has a higher risk of peristomal skin damage with irritant dermatitis by contact with corrosive effluents. The BodyFit technology (conforms to folds and irregularities of the skin) of SenSura Mio devices appears to be particularly suitable in this population to preserve the integrity of the peristomal skin.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ostomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants

There are not multiple groups in this study

Sensura Mio Bodyfit technology ostomy pouches

Intervention Type DEVICE

The use of medical devices, the ostomy pouches from Sensura Mio Bodyfit technology range, will be studied from inclusion visit (less than one month after the beginning of use) and during 3 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sensura Mio Bodyfit technology ostomy pouches

The use of medical devices, the ostomy pouches from Sensura Mio Bodyfit technology range, will be studied from inclusion visit (less than one month after the beginning of use) and during 3 months.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female aged over 18 year old
* Subject who signed the consent form
* Subject affiliated to a social security scheme or entitled to a social security benefit
* Subject with an ostomy less than one month old, with an expected stoma duration \> 3 months
* Subject presenting an enterostomy with liquid effluents (right colostomy, ileostomy, jejunostomy) or a urostomy, user of a high flow or drainable pouch (Uro)
* Subjects for which the healthcare professional decided to use the SenSura Mio Technology BodyFit™ as the first permanent ostomy appliance after surgery as part of the care routines
* Subject educated in ostomy care and who manages it himself in an autonomous or assisted manner.

Exclusion Criteria

* Vulnerable subject with regard to the regulations in force
* Pregnant, parturient or breastfeeding woman ;
* Subject deprived of liberty by judicial, medical or administrative decision;
* Minor subject;
* Subject legally protected or unable to express consent;
* Subject not affiliated or not benefiting from a social security system;
* Subject falling into several of the above categories;
* Subject who refused to participate in the study; and
* Subject participating in other research or clinical studies
* Subject for which stoma closure is scheduled before the end of the study
* A subject who, according to the investigator, has cognitive problems that prevent him or her from answering a questionnaire or for whom evaluation could be problematic.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratoires Coloplast S.A.S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guillaume Meurette, MD

Role: PRINCIPAL_INVESTIGATOR

Nantes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Du Pays D'Aix

Aix-en-Provence, , France

Site Status

Hotel Dieu

Angers, , France

Site Status

Centre Hospitalier d'Arras

Arras, , France

Site Status

Hopital de Mercy

Ars-Laquenexy, , France

Site Status

Centre Hospitalier Henri Mondor

Aurillac, , France

Site Status

Ch Henri Duffaut

Avignon, , France

Site Status

Clinique Belharra

Bayonne, , France

Site Status

Centre Hospitalier de Beauvais

Beauvais, , France

Site Status

Hopital Jean Minjoz

Besançon, , France

Site Status

Hopital La Cavale Blanche

Brest, , France

Site Status

Hopital Cote de Nacre

Caen, , France

Site Status

Centre Hospitalier de Douai

Cambrai, , France

Site Status

Hopital Du Pays D Autan

Castres, , France

Site Status

Hopital Manchester

Charleville-Mézières, , France

Site Status

Centre Hospitalier General

Châteauroux, , France

Site Status

Centre Hospitalier Du Cotentin Site de Cherbourg

Cherbourg Octeville, , France

Site Status

Hopital Beaujon

Clichy, , France

Site Status

Hopital Sud Francilien

Corbeil-Essonnes, , France

Site Status

Centre Georges François Leclerc

Dijon, , France

Site Status

Clinique Claude Bernard

Ermont, , France

Site Status

Cabinet infirmier

Étrelles, , France

Site Status

Centre Hospitalier Intercommunal Eure Seine

Évreux, , France

Site Status

Cabinet Infirmier

Flins-sur-Seine, , France

Site Status

Hopital Nord Ouest

Gleizé, , France

Site Status

Centre Hospitalier de Gonesse

Gonesse, , France

Site Status

Hopital Saint Louis

La Rochelle, , France

Site Status

Hopital La Source

La Source, , France

Site Status

Hopital Prive de L Estuaire

Le Havre, , France

Site Status

Pole Sante Sud

Le Mans, , France

Site Status

Centre Hospitalier Du Dr Schaffner

Lens, , France

Site Status

Hopital Robert Boulin

Libourne, , France

Site Status

Hopital Dupuytren

Limoges, , France

Site Status

Hopital Saint Philibert

Lomme, , France

Site Status

Hopital Nord

Marseille, , France

Site Status

Hopital Alphonse Laverand

Marseille, , France

Site Status

Hopital de La Conception

Marseille, , France

Site Status

Polyclinique Du Val de Saone

Mâcon, , France

Site Status

Centre Hospitalier Annecy Genevois Site Annecy

Metz-Tessy, , France

Site Status

Hopital Lapeyronie

Montpellier, , France

Site Status

Clinique St Augustin

Nantes, , France

Site Status

CHU Hôtel-Dieu

Nantes, , France

Site Status

Centre Hospitalier Georges Renon

Niort, , France

Site Status

Hopital Caremeau

Nîmes, , France

Site Status

Centre Hospitalier de Guingamp

Pabu, , France

Site Status

Hopital Saint Louis

Paris, , France

Site Status

Hopital Saint Antoine

Paris, , France

Site Status

Hopital Saint Antoine

Paris, , France

Site Status

Hopital Cochin

Paris, , France

Site Status

Hopital Bichat Claude Bernard

Paris, , France

Site Status

Hopital Europeen Georges Pompidou

Paris, , France

Site Status

Hopital Tenon

Paris, , France

Site Status

Centre Hospitalier Francois Mitterand

Pau, , France

Site Status

Hopital Saint Jean

Perpignan, , France

Site Status

Clinique Mutualiste de Pessac

Pessac, , France

Site Status

Centre Hospitalier Lyon Sud

Pierre-Bénite, , France

Site Status

Centre Hospitalier Universitaire La Miletrie

Poitiers, , France

Site Status

Hopital Pontchaillou

Rennes, , France

Site Status

Centre Hospitalier de Rochefort

Rochefort, , France

Site Status

Hopital Charles Nicolle

Rouen, , France

Site Status

Hopital Yves Le Foll

Saint-Brieuc, , France

Site Status

Centre Hospitalier St Charles

Saint-Dié, , France

Site Status

Cabinet infirmier

Saint-Hilaire-de-Riez, , France

Site Status

Hopital Nord

Saint-Priest-en-Jarez, , France

Site Status

Les Hopitaux Du Mont Blanc

Sallanches, , France

Site Status

Centre Hospitalier de Salon de Provence

Salon-de-Provence, , France

Site Status

Centre Hospitalier de Seclin/Carvin

Seclin, , France

Site Status

Hopital Civil

Strasbourg, , France

Site Status

Hopital Hautepierre

Strasbourg, , France

Site Status

Centre Hospitalier de La Gespe

Tarbes, , France

Site Status

Hopitaux Du Leman Site Thonon

Thonon-les-Bains, , France

Site Status

Hopital Sainte Musse

Toulon, , France

Site Status

Hopital Rangueil

Toulouse, , France

Site Status

Hopital Des Hauts Clos

Troyes, , France

Site Status

Centre Hospitalier General

Valence, , France

Site Status

Polyclinique Vauban

Valenciennes, , France

Site Status

Centre Hospitalier de Valenciennes

Valenciennes, , France

Site Status

Hopitaux de Brabois

Vandœuvre-lès-Nancy, , France

Site Status

Hopital Robert Schuman

Vantoux, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A03232-53

Identifier Type: OTHER

Identifier Source: secondary_id

2018-A03232-53

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA
Feasibility Study of a New Fistula Pouching System
NCT00294450 COMPLETED PHASE2/PHASE3